Feedback / Questions
ALZ-101 - Alzinova
http://prnewswire.com/news-releases/first-patient-recruited-into-alzinovas-phase-1b-clinical-study-with-the-oligomer-specific-alz-101-vaccine-against-alzheimers-disease-301411930.html
Oct 29, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next